FMP

FMP

Enter

TRVI - Trevi Therapeut...

photo-url-https://images.financialmodelingprep.com/symbol/TRVI.png

Trevi Therapeutics, Inc.

TRVI

NASDAQ

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

3.01 USD

0.065 (2.16%)

About

ceo

Ms. Jennifer L. Good

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

CIK

0001563880

ISIN

US89532M1018

CUSIP

89532M101

Address

195 Church Street

Phone

203 304 2499

Country

US

Employee

26

IPO Date

May 7, 2019

TRVI Financial Summary

CIK

0001563880

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

89532M101

ISIN

US89532M1018

Country

US

Price

3.01

Beta

0.97

Volume Avg.

346.26k

Market Cap

218.5M

Shares

-

52-Week

0.97-4.0

DCF

0.31

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-7.92

P/B

-

Website

https://www.trevitherapeutics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest TRVI News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep